The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Oncology Companion Diagnostics Market Increase Between 2026 And 2030?
Recent years have witnessed significant expansion in the size of the oncology companion diagnostics market. Projections indicate that it will increase from $3.79 billion in 2025 to $4.29 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.0%. This historical growth can be attributed to several factors, including the rising incidence of cancer types like breast, colorectal, and melanoma, a growing emphasis on personalized medicine, the increasing need for targeted therapy selection, the proliferation of diagnostic laboratories and hospitals, and advancements in molecular and genetic testing technologies.
The oncology companion diagnostics market size is anticipated to expand substantially over the coming years. It is projected to reach $6.5 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. This projected expansion during the forecast period is primarily driven by the increasing integration of next-generation sequencing (ngs) and pcr-based diagnostics, heightened collaboration between pharmaceutical and diagnostic enterprises, a rise in regulatory clearances for companion diagnostics, growing demand for precision oncology, and the expanded utilization of bioinformatics and decision support software in diagnostics. Prominent trends for this period encompass the escalating adoption of digital platforms for managing companion diagnostic data, greater incorporation of ai in biomarker analysis and patient stratification, the expanding application of genomics and precision medicine in targeted cancer therapy, increased automation in diagnostic testing and laboratory workflows, and the rising deployment of iot-enabled monitoring for diagnostic instruments and reagents.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15623&type=smp
Which Significant Factors Are Encouraging Growth In The Oncology Companion Diagnostics Market?
The anticipated increase in cancer cases is set to fuel the expansion of the oncology companion diagnostics market. Cancer refers to a multifaceted array of illnesses stemming from anomalous cells within the body that multiply and disseminate without regulation. This surge in cancer occurrences can be attributed to evolving lifestyles, environmental elements, the widespread obesity epidemic, tobacco consumption, and inherited genetic predispositions. Oncology companion diagnostics play a crucial role in precision medicine within oncology, fundamentally transforming cancer treatment by allowing for individualized therapy choices, boosting the effectiveness of treatments, reducing negative side effects, assisting in clinical trial participation, and refining the oversight of patient care. To illustrate, data released in May 2024 by the National Cancer Institute, a US-based government agency, reported approximately 20 million new cases and 9.7 million cancer-related deaths annually in 2022, with projections suggesting that by 2040, these figures could reach 15.3 million deaths and 29.9 million new cases per year. Consequently, the escalating number of cancer cases is a significant driver for the oncology companion diagnostics market.
How Is The Oncology Companion Diagnostics Market Examined Through Segment Analysis?
The oncology companion diagnostics market covered in this report is segmented –
1) By Product: Instrument, Consumables, Software
2) By Disease Type: Melanoma, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Other Disease Types
3) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH) Or Fluorescence In Situ Hybridization (FISH), Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies
4) By End User: Hospital, Pathology Or Diagnostic Laboratory, Academic Medical Center, Other End-Users
Subsegments:
1) By Instrument: Polymerase Chain Reaction (PCR) Instruments, Next-Generation Sequencing (NGS) Systems, Immunohistochemistry (IHC) Instruments, Fluorescence In Situ Hybridization (FISH) Instruments, Microarray Platforms
2) By Consumables: Reagents And Kits (DNA Or RNA Extraction Kits, PCR Reagents), Biopsy Needles, Testing Slides And Chips, Control And Calibration Samples
3) By Software: Data Analysis Software, Bioinformatics Software (For Gene Expression Analysis), Companion Diagnostic Decision Support Software, Clinical Workflow Management Software
Which Trends Are Expected To Shape The Oncology Companion Diagnostics Market?
Key companies operating within the oncology-based in vivo CRO market are focusing on developing novel solutions like CAR T-cell therapies to achieve a competitive advantage. CAR T-cell therapy is a form of immunotherapy that utilizes specifically modified T cells to combat cancer. As an illustration, in May 2023, Seattle Children’s Hospital and Research Institute, a US-based entity, launched BrainChild Bio to expedite CAR T-cell therapies for children suffering from brain tumors. The initial pediatric brain tumors BrainChild Bio intends to target with CAR T-cell therapy are diffuse intrinsic pontine gliomas (DIPG), an incurable childhood condition that originates in the brainstem. BrainChild Bio represents a next-generation CAR T-cell treatment platform that integrates synthetic technologies to maximize the effectiveness of CAR T-cell therapies for CNS malignancies. After securing pediatric registration for DIPG, BrainChild Bio plans to apply its innovative CAR T-cell therapy to treat a wider range of challenging adult and pediatric brain tumors, such as glioblastoma and brain metastases.
Who Are The Key Market Participants In The Oncology Companion Diagnostics Market?
Major companies operating in the oncology companion diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, BGI Genomics Co. Ltd., Natera Inc., Myriad Genetics Inc., ARUP Laboratories, NeoGenomics Laboratories Inc., Guardant Health, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Invivoscribe Inc., Pillar Biosciences Inc.
Access The Complete Oncology Companion Diagnostics Market Report:
Which Regional Market Leads The Oncology Companion Diagnostics Market?
North America was the largest region in the oncology companion diagnostic market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology companion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Oncology Companion Diagnostics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=15623&type=smp
Browse Through More Reports Similar to the Global Oncology Companion Diagnostics Market 2026, By The Business Research Company
Tumor Ablation Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report
Tumor Ablation Therapy Devices Global Market Report 2026
Ablation Technology Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ablation-technology-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model